Daily Cosmetic Research Analysis
Analyzed 14 papers and selected 3 impactful papers.
Summary
Analyzed 14 papers and selected 3 impactful articles.
Selected Articles
1. Silk fibroin nanofibers-GelMA hydrogel composite loaded with embryonic fibroblasts: A strategy for enhanced wound healing.
A bilayer GelMA/silk-fibroin composite engineered as a cell-delivery platform enhanced MEF viability and activity, improved hydrogel mechanics, and accelerated wound repair in vivo. It reduced pathological scarring and uniquely triggered wound-induced hair follicle neogenesis, indicating potential for functional skin regeneration with cosmetic benefits.
Impact: Demonstration of hair follicle neogenesis alongside accelerated healing and scar reduction is a notable advance for regenerative and aesthetic dermatology. The composite design provides a mechanistically plausible, translatable platform for next-generation wound care.
Clinical Implications: While preclinical, these data support pursuing human-grade cell sources and clinical translation of GelMA/SF scaffolds to achieve faster healing with less scarring and potential hair restoration in complex wounds and cosmetic reconstructions.
Key Findings
- SF nanofiber incorporation enhanced hydrogel compressive strength, water retention, and structural stability.
- The GelMA/SF composite supported high MEF viability and boosted proliferation and extracellular matrix synthesis in vitro.
- In full-thickness wounds, MEF-laden GelMA/SF accelerated healing by modulating inflammation, enhancing re-epithelialization, and stimulating angiogenesis with organized collagen deposition.
- The cell-loaded composite reduced pathological scarring and induced wound-induced hair follicle neogenesis.
Methodological Strengths
- Integrated materials characterization (mechanics, water retention) with cellular assays of viability and function.
- In vivo full-thickness wound model demonstrating multi-dimensional outcomes (inflammation, re-epithelialization, angiogenesis, collagen organization).
Limitations
- Preclinical animal model with mouse embryonic fibroblasts limits immediate generalizability to humans.
- Long-term durability, immune compatibility, and scalable GMP manufacturing remain untested.
Future Directions: Validate with human-appropriate cells (adult dermal fibroblasts, MSCs), test in large-animal models, and dissect mechanisms of folliculogenesis (e.g., Wnt signaling) to guide clinical translation and scarless skin regeneration.
Synthetic and natural polymer scaffolds have been widely utilized in the design of wound dressings to promote skin tissue regeneration and repair. This study developed an innovative bilayer wound dressing by integrating electrospun silk fibroin (SF) nanofibers into a photo-crosslinkable gelatin methacryloyl (GelMA) hydrogel, creating a GelMA/SF composite scaffold specifically designed as a delivery platform for mouse embryonic fibroblasts (MEFs). The incorporation of SF nanofibers substantially improved the compressive stress, water retention capacity, and structural stability of the hydrogel, thereby providing a more stable and supportive microenvironment for the loaded MEFs. In vitro, the GelMA/SF composite not only supported high cell viability but also significantly enhanced the biological activity of the encapsulated MEFs, facilitating their proliferation and extracellular matrix synthesis. In a full-thickness skin wound model, the MEFs-laden GelMA/SF composite actively accelerated wound healing by effectively modulating inflammation, enhancing re-epithelialization, stimulating angiogenesis, and promoting organized collagen deposition. Moreover, this cell-loaded composite system markedly inhibited pathological scarring and uniquely induced wound-induced hair follicle neogenesis. These findings demonstrate that the GelMA/SF composite serves as a highly effective cell delivery platform, enabling functional skin regeneration with reduced scar formation.
2. First Repair is Best: The Facial Growth Consequences of Revision Cleft Surgeries.
In 106 skeletally mature CLP patients, more cleft-related surgeries—especially between ages 0–5—were independently associated with reduced SNA, ANB, facial convexity, and alveolar length, while bilateral clefts had narrower maxillary width than unilateral cases. Each operation beyond three predicted substantial decrements in cephalometric indices, underscoring the growth costs of repeated revisions.
Impact: This study quantifies the cephalometric penalties of early, repeated cleft surgeries, providing actionable targets (surgical timing and minimizing revisions) to protect maxillary growth.
Clinical Implications: Prioritize meticulous, growth-preserving primary repairs and avoid early additional interventions when feasible; incorporate quantified risks into shared decision-making and long-term orthodontic-surgical planning.
Key Findings
- In 106 CLP patients, bilateral clefts had significantly reduced maxillary width versus unilateral clefts (-2.87 mm; p=0.001).
- Greater total number of cleft surgeries correlated with decreased SNA, ANB, and facial convexity angles (p<0.001).
- Surgeries at ages 0–5 were associated with decreased SNA, facial convexity angle, and alveolar length (p<0.02).
- Each surgery beyond three predicted reductions in SNA (-1.94°), ANB (-0.81°), and facial convexity (-2.82°).
- Surgical burden did not predict the need for orthognathic surgery.
Methodological Strengths
- Objective cephalometric assessment using cone beam CT and standardized software.
- Multivariable linear and logistic regression to identify independent predictors.
Limitations
- Retrospective design with potential residual confounding (e.g., surgical technique heterogeneity).
- Cephalometric outcomes are cross-sectional at skeletal maturity, limiting causal inference on growth trajectories.
Future Directions: Prospective registries with standardized protocols and technique-specific analyses; evaluate scarring-minimizing approaches and optimal timing to preserve maxillary growth.
PURPOSE: Surgical scarring has long been hypothesized to contribute to maxillary hypoplasia in patients with cleft lip and palate (CLP), often leading to a need for orthognathic surgery (OGS). This study aimed to identify clinical and surgical factors associated with maxillary hypoplasia in skeletally mature patients with CLP using cephalometric analysis. METHODS: A retrospective review was performed of CLP patients aged ≥16 years with available cone beam CT scans. Cephalometric measurements were obtained using Mimics software. Patient records were reviewed for cleft morphology, number and type of cleft-related surgeries (ages 0-16), surgical timing, demographics, and history of OGS. Linear and logistic regressions were used to evaluate predictors of maxillary hypoplasia and OGS. RESULTS: Among 106 patients, 47.2% had bilateral CLP and 49.1% underwent OGS. The average number of cleft-related surgeries was 4.28. BCLP patients demonstrated significantly reduced maxillary width compared to UCLP (-2.87 mm, p = 0.001). Increasing total number of surgeries was significantly associated with decreased SNA, ANB, and facial convexity angles (p < 0.001). Surgeries performed between ages 0-5 were significantly associated with decreased SNA, facial convexity angle, and alveolar length (p < 0.02). Linear regression showed that each surgery beyond three predicted a 1.94° reduction in SNA, 0.81° reduction in ANB, and 2.82° reduction in facial convexity angle. Surgical burden was not predictive of OGS. CONCLUSIONS: Greater number of cleft-related surgeries, particularly in early childhood, correlates directly with maxillary growth restriction. These findings highlight the importance of optimizing surgical timing and minimizing additional interventions when feasible.
3. Endovenous laser ablation of tributary varicose veins: A literature review and recent initiatives in Japan.
A narrative synthesis highlights how a 1470-nm radial 2-ring slim fiber enables incision-free endovenous ablation of tributary veins via a 16-G needle. Japanese multicenter data (400 cases) achieved 100% 1-month occlusion without severe complications, prompting 2025 national guideline recognition and suggesting favorable cosmetic outcomes versus incision-based methods.
Impact: Technique evolution with national endorsement and multicenter outcomes signals a meaningful shift toward minimally invasive, cosmetically favorable treatment of tributary varicosities.
Clinical Implications: Consider R2SF-based VVA as a third-line option alongside stab avulsion and sclerotherapy, particularly when incisionless, cosmetically favorable outcomes are prioritized. Establish training and credentialing to ensure technical proficiency and safety.
Key Findings
- A 1470-nm radial 2-ring slim fiber enables uniform, incision-free endovenous ablation via a 16-G needle.
- Japanese multicenter experience (n=400) reported 100% 1-month occlusion with no severe complications; transient subdermal induration was common but self-limited.
- The 2025 Japanese guidelines recognized VVA as a third treatment option alongside stab avulsion and sclerotherapy.
- Author’s >1700-case experience suggests low complication rates and favorable cosmetic outcomes.
Methodological Strengths
- Synthesizes multicenter clinical experience and aligns with formal guideline endorsement.
- Highlights technical innovations addressing prior safety concerns (burns, nerve injury) of bare-tip fibers.
Limitations
- Narrative (non-systematic) review with potential selection bias and limited comparative data.
- Short-term occlusion outcomes predominate; long-term durability and international generalizability remain uncertain.
Future Directions: Prospective international registries and randomized comparisons versus stab avulsion/sclerotherapy; assess long-term occlusion, recurrence, patient-reported cosmetic/QoL outcomes, and cost-effectiveness.
BackgroundEndovenous laser ablation (EVLA) has become a standard treatment for saphenous trunk reflux. However, its application to tributary varicose veins-referred to as varicose vein ablation (VVA)-has not been well recognized. Early reports using bare-tip fibers were associated with relatively high rates of postoperative complications, including skin burns and nerve injuries, which limited worldwide acceptance of this approach.MethodsThis narrative review summarizes 14 relevant publications, including a recent Japanese multicenter study and guideline development initiatives. Particular attention is given to the introduction of a 1470-nm radial 2-ring slim fiber (R2SF), its technical characteristics, and nationwide clinical experience in Japan. Educational and certification programs initiated by the Japanese Society of Phlebology are also reviewed.ResultsThe R2SF enables uniform endovenous laser ablation via a 16-G venous needle without skin incisions. A Japanese multicenter study involving 400 cases demonstrated complete vein occlusion at 1 month in all treated veins, with no severe complications. Based on accumulating clinical data, the 2025 Japanese guidelines recognized VVA as the third treatment option alongside stab avulsion and sclerotherapy. The author's experience of over 1700 cases further supports low complication rates and favorable cosmetic outcomes. Transient subdermal induration is relatively common but resolves spontaneously without infection or skin damage.ConclusionsVVA using an R2SF represents a safe, minimally invasive, and incision-free approach for treating tributary varicose veins. The Japanese experience, supported by guideline endorsement and national training systems, suggests that VVA may complement some limitations of stab avulsion. Long-term observation and international validation are necessary.